Renalytix repays $1.06M of convertible bond via ADS issuance; principal reduced to $15.9M

Renalytix plc

Repaid $1.06M of convertible bond by issuing 526,211 American Depositary Shares (1,052,422 ordinary shares).
Remaining principal under the convertible bond after settlement is $15.90M.
New ordinary shares admitted to trading on AIM effective July 19, 2023.
Post-admission total ordinary shares outstanding: 94,833,900.
Announcement corrects prior figure for principal remaining from earlier release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.